We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLAD icon
2126
Gladstone Capital
GLAD
$430M
$292K ﹤0.01%
12,140
-48,332
-80% -$1.13M
BLUA.WS
2127
CALL
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$292K ﹤0.01%
27,670
GDRX icon
2128
GoodRx Holdings
GDRX
$1.03B
$292K ﹤0.01%
42,010
-66,090
-61% -$519K
ALXO icon
2129
ALX Oncology
ALXO
$272M
$291K ﹤0.01%
160,059
-475,620
-75% -$1.77M
CGON icon
2130
CG Oncology
CGON
$6.48B
$291K ﹤0.01%
7,700
-68,282
-90% -$2.39M
FCFS icon
2131
FirstCash
FCFS
$9.06B
$290K ﹤0.01%
2,530
-17,747
-88% -$2.01M
CNH
2132
CNH Industrial
CNH
$13.7B
$289K ﹤0.01%
26,046
-2,927,959
-99% -$29.8M
SBDS
2133
DELISTED
Solo Brands Inc
SBDS
$288K ﹤0.01%
5,107
-3,149
-38% -$224K
NLY icon
2134
Annaly Capital Management
NLY
$16.9B
$288K ﹤0.01%
+14,338
New +$287K
AXTI icon
2135
AXT Inc
AXTI
$3.13B
$288K ﹤0.01%
118,860
+95,758
+415% +$271K
PANL icon
2136
Pangaea Logistics
PANL
$488M
$288K ﹤0.01%
39,774
-8,862
-18% -$61.2K
FC icon
2137
Franklin Covey
FC
$245M
$287K ﹤0.01%
+6,977
New +$280K
PCOR icon
2138
Procore
PCOR
$7.03B
$285K ﹤0.01%
4,618
-232,158
-98% -$14.2M
VINP icon
2139
Vinci Compass Investments Ltd
VINP
$637M
$284K ﹤0.01%
+28,633
New +$305K
HD icon
2140
PUT
Home Depot
HD
$335B
$284K ﹤0.01%
700
AX icon
2141
Axos Financial
AX
$5.45B
$283K ﹤0.01%
+4,503
New +$296K
SRTA
2142
Strata Critical Medical Inc
SRTA
$445M
$282K ﹤0.01%
+95,849
New +$305K
SXI icon
2143
Standex International
SXI
$3.75B
$282K ﹤0.01%
+1,541
New +$268K
VXF icon
2144
Vanguard Extended Market ETF
VXF
$30.5B
$282K ﹤0.01%
+1,547
New +$270K
SOWG
2145
Sow Good
SOWG
$64.4M
$281K ﹤0.01%
1,605
-4,475
-74% -$1.06M
BAX icon
2146
Baxter International
BAX
$12.1B
$279K ﹤0.01%
7,344
-40,466
-85% -$1.49M
ALLT icon
2147
Allot
ALLT
$373M
$279K ﹤0.01%
+93,794
New +$282K
FFBC icon
2148
First Financial Bancorp
FFBC
$3.52B
$278K ﹤0.01%
+11,000
New +$276K
DC icon
2149
Dakota Gold
DC
$642M
$277K ﹤0.01%
117,227
-143,783
-55% -$329K
GEO icon
2150
The GEO Group
GEO
$4.13B
$277K ﹤0.01%
21,519
+5,219
+32% +$72.8K

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.